Pfizer R&D Center

Pfizer, a leader among global biopharmaceutical companies, has been established in China since the 1980s. Pfizer’s presence and activities in China started with commercial offices, and has evolved to include manufacturing (e.g., several plants commenced operations in China during the 1980s and 1990s, including Dalian and Suzhou), as well as R&D – with the establishment of Pfizer’s China R&D Center (CRDC) in Shanghai in 2005. The last decade has seen a significant expansion of Pfizer’s R&D footprint, facilities and capabilities, notably with the launch of CRDC’s sister satellite R&D site in Wuhan in 2010. Currently the market leader among multinational biopharmaceutical companies in China, Pfizer has approximately 1,000 R&D colleagues working in China, with a concentration in three key sites affiliated to CRDC – namely Shanghai, Wuhan and Beijing.